Hyperbaric oxygen therapy in combination with systemic treatment of sickle cell disease presenting as central retinal artery occlusion: a case report

Journal of Medical Case Reports

Rana Altan-Yaycioglu¹  Burak Ulas¹  Handan Canan¹ 

[1] Department of Ophthalmology, Baskent University School of Medicine, Dadaloglu mah, Serinevler 2591 No 4/A 01250, Yuregır, Adana, Turkey

关键词: Sickle Cell Disease;    Retinal Artery Occlusion;    Hyperbaric Oxygen Therapy;   

Others  :  1180983
DOI  :  10.1186/1752-1947-8-370

 received in 2014-05-07, accepted in 2014-09-17,  发布年份 2014

【 摘 要 】

Introduction

We describe hyperbaric oxygen therapy for the treatment of central retinal artery occlusion in a young adult with sickle cell disease.

Case presentation

A 25-year-old Turkish man with a history of sickle cell disease developed sudden painless loss of vision in the left eye and was hospitalized for diagnosis and treatment. Central retinal artery occlusion was diagnosed with retinal whitening, cherry red spot, and delayed arteriovenous transit on fluorescein angiography. He underwent exchange transfusion and hyperbaric oxygen therapy. In the following three months, his visual acuity improved to 20/30.

Conclusions

In this present case with sickle cell disease, the visual acuity improved with hyperbaric oxygen therapy in addition to systemic therapy. The result of our case suggests that hyperbaric oxygen therapy may be beneficial in the treatment of central retinal artery occlusion.

【 授权许可】

   
2014 Canan et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

【 参考文献 】

• [1]Brown GC, Magargal LE, Shields JA, Goldberg RE, Walsh PN: Retinal arterial obstruction in children and young adults. Ophthalmology 1981, 88:18-25.
• [2]Yanoff M, Duker JS: Ophthalmology. St. Louis: Mosby, Inc; 2004:1678.
• [3]Downes SM, Hambleton IR, Chuang EL, Lois N, Serjeant GR, Bird AC: Incidence and natural history of proliferative sickle cell retinopathy: observations from a cohort study. Ophthalmology 2005, 112:1869-1875.
• [4]Clarkson JG: The ocular manifestations of sickle-cell disease: a prevalence and natural history study. Trans Am Ophthalmol Soc 1992, 90:481-504.
• [5]Sanghvi C, Laude A, Smith A, Dodd CL: Superior macular sparing in central retinal artery occlusion due to sickle cell anaemia. Eye (Lond) 2004, 18:442-443.
• [6]Liem RI, Calamaras DM, Chhabra MS, Files B, Minniti CP, Thompson AA: Sudden-onset blindness in sickle cell disease due to retinal artery occlusion. Pediatr Blood Cancer 2008, 50:624-627.
• [7]Al-Abdulla NA, Haddock TA, Kerrison JB, Goldberg MF: Sickle cell disease presenting with extensive peri-macular arteriolar occlusions in a nine-year-old boy. Am J Ophthalmol 2001, 131:275-276.
• [8]Beiran I, Goldenberg I, Adir Y, Tamir A, Shupak A, Miller B: Early hyperbaric oxygen therapy for retinal artery occlusion. Eur J Ophthalmol 2001, 11:345-350.
• [9]Weinberger AW, Siekmann UP, Wolf S, Rossaint R, Kirchhof B, Schrage NF: Treatment of acute central retinal artery occlusion (CRAO) by hyperbaric oxygenation therapy (HBO)-Pilot study with 21 patients. Klin Monbl Augenheilkd 2002, 219:728-734.
• [10]Oguz H, Sobaci G: The use of hyperbaric oxygen therapy in ophthalmology. Surv Ophthalmol 2008, 53:112-120.
• [11]Aisenbrey S, Krott R, Heller R, Krauss D, Rössler G, Heimann K: Hyperbaric oxygen therapy in retinal artery occlusion. Ophthalmologe 2000, 97:461-467.
• [12]Wallyn CR, Jampol LM, Goldberg MF, Zanetti CL: The use of hyperbaric oxygen therapy in the treatment of sickle cell hyphema. Invest Ophthalmol Vis Sci 1985, 26:1155-1158.
• [13]Menzel-Severing J, Siekmann U, Weinberger A, Roessler G, Walter P, Mazinani B: Early hyperbaric oxygen treatment for nonarteritic central retinal artery obstruction. Am J Ophthalmol 2012, 153:454-459.